Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Cibus, Inc. Director's Dealing 2023

Jun 2, 2023

34396_dirs_2023-06-01_85644268-536b-4b86-a036-c43af2eade7d.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cibus, Inc. (CLXT)
CIK: 0001705843
Period of Report: 2023-03-01

Reporting Person: Dumont Philippe (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2023-03-01 Stock Option (Right-to-Buy) $4.55 D 5000 Disposed 2030-08-04 Common Stock (5000) Direct
2023-03-01 Stock Option (Right-to-Buy) $4.55 A 5000 Acquired 2030-08-04 Common Stock (5000) Direct
2023-03-01 Stock Option (Right-to-Buy) $4.22 D 10291 Disposed 2031-05-27 Common Stock (10291) Direct
2023-03-01 Stock Option (Right-to-Buy) $4.22 A 10291 Acquired 2031-05-27 Common Stock (10291) Direct
2023-03-01 Stock Option (Right-to-Buy) $0.3032 D 32700 Disposed 2032-06-13 Common Stock (32700) Direct
2023-03-01 Stock Option (Right-to-Buy) $0.3032 A 32700 Acquired 2032-06-13 Common Stock (32700) Direct

Footnotes

F1: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split.